[Alpha2-macroglobulin in diabetic disease and in its microangiopathic complications].

The role of alfa2-macroglobulin in diabetic microangiopathy pathogenesis is described. A study of the behaviour of this protein in a group of diabetic patients with and without microangiopathy and in a control group of healthy patients has been carried out. It has been found that the protein greatly increases in diabetic patients with microangiopathy. On the basis of these results, it is suggested that dosage of alfa2-macroglobulin can be a possible test for evaluating microangiopathic complications in diabetes.